Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Clinical trial NCT01700946 · COMPLETED

Trial details

NCT number: NCT01700946
Sponsor: St. Jude Children's Research Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma

Start date: 2013-04-15
Primary completion: 2021-07-24
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.